Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| FATE Historical Stock Prices |
| Preferred Stock Newsletter |
| FATE Options Chain |
| Stock Message Boards |
Fate Therapeutics (FATE) has the following price history information. Looking back at FATE historical stock prices for the last five trading days, on April 15, 2024, FATE opened at $5.80, traded as high as $5.96 and as low as $5.39, and closed at $5.64. Trading volume was a total of 2.69M shares. On April 16, 2024, FATE opened at $5.53, traded as high as $5.74 and as low as $5.32, and closed at $5.38. Trading volume was a total of 2.82M shares. On April 17, 2024, FATE opened at $5.50, traded as high as $5.63 and as low as $5.21, and closed at $5.27. Trading volume was a total of 2.15M shares. On April 18, 2024, FATE opened at $5.27, traded as high as $5.35 and as low as $4.98, and closed at $5.04. Trading volume was a total of 2.34M shares. On April 19, 2024, FATE opened at $4.95, traded as high as $5.11 and as low as $4.70, and closed at $4.79. Trading volume was a total of 2.69M shares.
FATE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Fate Therapeutics shares, starting with a $10,000 purchase of FATE, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 04/22/2014 | |
| End date: | 04/19/2024 | |
| Start price/share: | $7.11 | |
| End price/share: | $4.79 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -32.63% | |
| Average Annual Total Return: | -3.87% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $6,738.91 | |
| Years: | 10.00 | |
 | |||||
| FATE Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 04/15/2024 | $5.80 | $5.96 | $5.39 | $5.64 | 2.69M |
| 04/16/2024 | $5.53 | $5.74 | $5.32 | $5.38 | 2.82M |
| 04/17/2024 | $5.50 | $5.63 | $5.21 | $5.27 | 2.15M |
| 04/18/2024 | $5.27 | $5.35 | $4.98 | $5.04 | 2.34M |
| 04/19/2024 | $4.95 | $5.11 | $4.70 | $4.79 | 2.69M |
|
| About Fate Therapeutics |
| Fate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of programmed cellular immunotherapies for patients with cancer. Co. is developing cell therapy product candidate. Co.'s off-the-shelf, induced pluripotent stem cells (iPSC) derived cellular immunotherapy pipeline include: FT516, which is an off-the-shelf natural killer (NK) cell cancer immunotherapy derived from a clonal master iPSC line engineered to express a high-affinity, non-cleavable CD16 Fc receptor; and FT596, which is an off-the-shelf chimeric antigen receptor NK cell cancer immunotherapy derived from a clonal engineered master iPSC line. |
| FATE Historical Closing Prices | |
| Date | Close |
| 04/15/2024 | $5.64 |
| 04/16/2024 | $5.38 |
| 04/17/2024 | $5.27 |
| 04/18/2024 | $5.04 |
| 04/19/2024 | $4.79 |
| Healthcare Historical Prices |
| FATE is categorized under the Healthcare sector; below are some other companies in the same sector:
FCRE Historical Stock Prices Also explore: FATE shares outstanding history
|
Free FATE Email Alerts:
FATE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.